| UniProt ID | ZN496_HUMAN | |
|---|---|---|
| UniProt AC | Q96IT1 | |
| Protein Name | Zinc finger protein 496 | |
| Gene Name | ZNF496 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 587 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | DNA-binding transcription factor that can both act as an activator and a repressor.. | |
| Protein Sequence | MPTALCPRVLAPKESEEPRKMRSPPGENPSPQGELPSPESSRRLFRRFRYQEAAGPREALQRLWDLCGGWLRPERHTKEQILELLVLEQFLAILPREIQSWVRAQEPESGEQAVAAVEALEREPGRPWQWLKHCEDPVVIDDGDSPLDQEQEQLPVEPHSDLAKNQDAQPITLAQCLGLPSRPPSQLSGDPVLQDAFLLQEENVRDTQQVTTLQLPPSRVSPFKDMILCFSEEDWSLLDPAQTGFYGEFIIGEDYGVSMPPNDLAAQPDLSQGEENEPRVPELQDLQGKEVPQVSYLDSPSLQPFQVEERRKREELQVPEFQACPQTVVPQNTYPAGGNPRSLENSLDEEVTIEIVLSSSGDEDSQHGPYCTEELGSPTEKQRSLPASHRSSTEAGGEVQTSKKSYVCPNCGKIFRWRVNFIRHLRSRREQEKPHECSVCGELFSDSEDLDGHLESHEAQKPYRCGACGKSFRLNSHLLSHRRIHLQPDRLQPVEKREQAASEDADKGPKEPLENGKAKLSFQCCECGKAFQRHDHLARHRSHFHLKDKARPFQCRYCVKSFTQNYDLLRHERLHMKRRSKQALNSY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 13 | Sumoylation | CPRVLAPKESEEPRK CCCCCCCCCCCCCCC | 69.16 | 28112733 | |
| 13 (in isoform 2) | Ubiquitination | - | 69.16 | - | |
| 13 | Ubiquitination | CPRVLAPKESEEPRK CCCCCCCCCCCCCCC | 69.16 | - | |
| 23 | Phosphorylation | EEPRKMRSPPGENPS CCCCCCCCCCCCCCC | 31.76 | 30266825 | |
| 30 | Phosphorylation | SPPGENPSPQGELPS CCCCCCCCCCCCCCC | 41.24 | 30266825 | |
| 37 | Phosphorylation | SPQGELPSPESSRRL CCCCCCCCHHHHHHH | 54.66 | 30266825 | |
| 50 | Phosphorylation | RLFRRFRYQEAAGPR HHHHHHHHHHHHCHH | 14.16 | 30622161 | |
| 181 | Phosphorylation | AQCLGLPSRPPSQLS HHHHCCCCCCHHHHC | 63.56 | 26074081 | |
| 185 | Phosphorylation | GLPSRPPSQLSGDPV CCCCCCHHHHCCCCH | 46.57 | 20044836 | |
| 188 | Phosphorylation | SRPPSQLSGDPVLQD CCCHHHHCCCCHHHH | 33.25 | 28387310 | |
| 218 | Phosphorylation | TTLQLPPSRVSPFKD EEEECCHHHCCCCCC | 43.29 | 26074081 | |
| 221 | Phosphorylation | QLPPSRVSPFKDMIL ECCHHHCCCCCCEEE | 24.41 | 30266825 | |
| 269 | Ubiquitination | NDLAAQPDLSQGEEN HHCCCCCCCCCCCCC | 47.04 | 21963094 | |
| 289 | Ubiquitination | ELQDLQGKEVPQVSY HHHHHCCCCCCCCEE | 42.45 | 21906983 | |
| 295 | Phosphorylation | GKEVPQVSYLDSPSL CCCCCCCEECCCCCC | 18.09 | 26074081 | |
| 296 | Phosphorylation | KEVPQVSYLDSPSLQ CCCCCCEECCCCCCC | 18.70 | 26074081 | |
| 299 | Phosphorylation | PQVSYLDSPSLQPFQ CCCEECCCCCCCCCC | 17.50 | 28112733 | |
| 301 | Phosphorylation | VSYLDSPSLQPFQVE CEECCCCCCCCCCHH | 43.52 | 26074081 | |
| 325 | Ubiquitination | VPEFQACPQTVVPQN CCCCCCCCCCCCCCC | 35.57 | 21963094 | |
| 325 (in isoform 2) | Ubiquitination | - | 35.57 | - | |
| 388 | Phosphorylation | KQRSLPASHRSSTEA HHHCCCCCCCCCCCC | 19.93 | 25627689 | |
| 391 | Phosphorylation | SLPASHRSSTEAGGE CCCCCCCCCCCCCCC | 35.87 | 27251275 | |
| 392 | Phosphorylation | LPASHRSSTEAGGEV CCCCCCCCCCCCCCE | 30.17 | 25159151 | |
| 393 | Phosphorylation | PASHRSSTEAGGEVQ CCCCCCCCCCCCCEE | 30.97 | 25627689 | |
| 403 | Sumoylation | GGEVQTSKKSYVCPN CCCEECCCCCEECCC | 49.48 | 28112733 | |
| 403 | Sumoylation | GGEVQTSKKSYVCPN CCCEECCCCCEECCC | 49.48 | - | |
| 404 | Sumoylation | GEVQTSKKSYVCPNC CCEECCCCCEECCCC | 46.95 | - | |
| 404 | Sumoylation | GEVQTSKKSYVCPNC CCEECCCCCEECCCC | 46.95 | - | |
| 445 | Phosphorylation | SVCGELFSDSEDLDG CCCHHHCCCCCCCCC | 53.50 | 30576142 | |
| 447 | Phosphorylation | CGELFSDSEDLDGHL CHHHCCCCCCCCCCH | 31.63 | - | |
| 496 | Sumoylation | DRLQPVEKREQAASE CCCCCHHHHHHHHHC | 62.56 | 28112733 | |
| 496 | Sumoylation | DRLQPVEKREQAASE CCCCCHHHHHHHHHC | 62.56 | - | |
| 519 | Sumoylation | PLENGKAKLSFQCCE CCCCCCEEEEEEECC | 48.42 | - | |
| 519 | Sumoylation | PLENGKAKLSFQCCE CCCCCCEEEEEEECC | 48.42 | - | |
| 561 | Phosphorylation | QCRYCVKSFTQNYDL CCHHHHHHHHHCHHH | 17.09 | 26503514 | |
| 580 | Phosphorylation | RLHMKRRSKQALNSY HHHHHHHHHHHHHCC | 32.90 | 29083192 | |
| 586 | Phosphorylation | RSKQALNSY------ HHHHHHHCC------ | 32.82 | 29083192 | |
| 587 | Phosphorylation | SKQALNSY------- HHHHHHCC------- | 22.85 | 29083192 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN496_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN496_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN496_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NSD1_HUMAN | NSD1 | physical | 15169884 | |
| TIF1B_HUMAN | TRIM28 | physical | 20176155 | |
| CBX3_HUMAN | CBX3 | physical | 20176155 | |
| ZN483_HUMAN | ZNF483 | physical | 25416956 | |
| ZSC22_HUMAN | ZSCAN22 | physical | 25416956 | |
| ZKSC4_HUMAN | ZKSCAN4 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-299, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-185, AND MASSSPECTROMETRY. | |